6.80新台幣0.1(1.45%)
2025/07/15更新
績效 / 1月0.72%
3月6.5%
1年24.59%
晨星評等-
- 1.現金9.83%
- 2.股票17.79%
- 3.債券0.00%
- 4.其他72.38%
- 1.美國73.61%
- 2.已開發亞洲6.55%
- 3.英國3.68%
- 4.新興亞洲2.98%
- 5.歐洲不包含歐元區1.80%
- 1.Eli Lilly and Co8.99%
- 2.Gilead Sciences Inc6.88%
- 3.Intuitive Surgical Inc5.85%
- 4.Boston Scientific Corp4.76%
- 5.Lotus Pharmaceutical Co Ltd3.97%
- 6.AstraZeneca PLC ADR3.64%
- 7.Bristol-Myers Squibb Co3.44%
- 8.Thermo Fisher Scientific Inc3.31%
- 9.SPDR® S&P Biotech ETF3.21%
- 10.argenx SE ADR2.98%
- 1.現金9.83%
- 2.股票17.79%
- 3.債券0.00%
- 4.其他72.38%
- 1.美國73.61%
- 2.已開發亞洲6.55%
- 3.英國3.68%
- 4.新興亞洲2.98%
- 5.歐洲不包含歐元區1.80%
- 1.Eli Lilly and Co8.99%
- 2.Gilead Sciences Inc6.88%
- 3.Intuitive Surgical Inc5.85%
- 4.Boston Scientific Corp4.76%
- 5.Lotus Pharmaceutical Co Ltd3.97%
- 6.AstraZeneca PLC ADR3.64%
- 7.Bristol-Myers Squibb Co3.44%
- 8.Thermo Fisher Scientific Inc3.31%
- 9.SPDR® S&P Biotech ETF3.21%
- 10.argenx SE ADR2.98%